European Neuropsychopharmacology
Volume 21, Issue 4 , Pages 294-299 , April 2011

Searching for functional SNPs or rare variants in exonic regions of DRD3 in risperidone-treated patients

  • Patricia Gassó

      Affiliations

    • Dept. of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Casanova 143, E-08036 Barcelona, Spain
    • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBER-SAM), Spain
    • ,
  • Sergi Mas

      Affiliations

    • Dept. of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Casanova 143, E-08036 Barcelona, Spain
    • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBER-SAM), Spain
    • ,
  • Cristina Oliveira

      Affiliations

    • Psychiatry Service, Hospital Clinic de Barcelona, Villarroel 170, E-08036 Barcelona, Spain
    • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBER-SAM), Spain
    • ,
  • Miquel Bioque

      Affiliations

    • Psychiatry Service, Hospital Clinic de Barcelona, Villarroel 170, E-08036 Barcelona, Spain
    • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBER-SAM), Spain
    • ,
  • Eduard Parellada

      Affiliations

    • Psychiatry Service, Hospital Clinic de Barcelona, Villarroel 170, E-08036 Barcelona, Spain
    • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBER-SAM), Spain
    • ,
  • Miquel Bernardo

      Affiliations

    • Psychiatry Service, Hospital Clinic de Barcelona, Villarroel 170, E-08036 Barcelona, Spain
    • Dept. of Psychiatry and Clinical Psychobiology, University of Barcelona, Casanova 143, E-08036 Barcelona, Spain
    • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBER-SAM), Spain
    • ,
  • Gemma Trias

      Affiliations

    • Dept. of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Casanova 143, E-08036 Barcelona, Spain
    • ,
  • Joaquim Comeche

      Affiliations

    • Dept. of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Casanova 143, E-08036 Barcelona, Spain
    • ,
  • Amalia Lafuente

      Affiliations

    • Dept. of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, Casanova 143, E-08036 Barcelona, Spain
    • Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Barcelona, Spain
    • Centro de Investigación Biomédica en Red de Salud Mental (CIBER-SAM), Spain
    • Corresponding Author InformationCorresponding author. Dept. of Anatomic Pathology, Pharmacology and Microbiology, University of Barcelona, IDIBAPS, Casanova 143, E-08036 Barcelona, CIBER-SAM (Centro de Investigación Biomédica en Red de Salud Mental, Spanish Ministry of Health, Instituto Carlos III), Spain. Tel.: +34 0034934024526; fax: +34 0034934035881.

Received 16 February 2010 ,Revised 30 April 2010 ,Accepted 12 June 2010.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington DC: American Psychiatric Press; 1994;
  2. Bakker PR, van Harten PN, van Os J. Antipsychotic-induced tardive dyskinesia and the Ser9Gly polymorphism in the DRD3 gene: a meta analysis. Schizophr. Res. 2006;83:185–192
  3. Bressan RA, Erlandsson K, Jones HM, et al. Is regionally selective D2/D3 dopamine occupancy sufficient for atypical antipsychotic effect? An in vivo quantitative [123I]epidepride SPET study of amisulpride-treated patients. Am. J. Psychiatry. 2003;160:1413–1420
  4. Conde L, Vaquerizas JM, Dopazo H, et al. PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes. Nucleic Acids Res. 2006;34:W621–W625(Web Server issue)
  5. Costas J, Carrera N, Domínguez E, et al. A common haplotype of DRD3 affected by recent positive selection is associated with protection from schizophrenia. Hum. Genet. 2009;124(6):607–613
  6. Eichhammer P, Albus M, Borrmann-Hassenbach M, et al. Association of dopamine D3-receptor gene variants with neuroleptic induced akathisia in schizophrenic patients: a generalization of Steen's study on DRD3 and tardive dyskinesia. Am. J. Med. Genet. 2000;96(2):187–191
  7. Fink-Jensen A, Nielsen EB, Hansen L, Scheideler MA. Behavioral and neurochemical effects of the preferential dopamine D3 receptor agonist cis-8-OH-PBZI. Eur. J. Pharmacol. 1998;342(2–3):153–161
  8. First MB, Spitzer RL, Williams JBW, Gibbon M. Structured Clinical Interview for DSM-IV- Patients edition (SCID-P). Washington DC: American Psychiatric Press; 1994;
  9. Gasso P, Mas S, Bernardo M, Álvarez S, Parellada E, Lafuente A. A common variante in DRD3 gene is associated with risperidone-induced extrapiramidal symptoms. Pharmacogenomics J. 2009;
  10. González JR, Armengol L, Solé X, et al. SNPassoc: an R package to perform whole genome association studies. Bioinformatics. 2007;23:644–645
  11. Gorlov IP, Gorlova OY, Sunyaev SR, Spitz MR, Amos CI. Shifting paradigm of association studies: value of rare single-nucleotide polymorphisms. Am. J. Hum. Genet. 2008;82(1):100–112
  12. Graff-Guerrero A, Mamo D, Shammi CM, et al. The effect of antipsychotics on the high-affinity state of D2 and D3 receptors: a positron emission tomography study With [11C]-(+)-PHNO. Arch. Gen. Psychiatry. 2009;66(6):606–615
  13. Gunes A, Scordo MG, Jaanson P, Dahl ML. Serotonin and dopamine receptor gene polymorphisms and the risk of extrapyramidal side effects in perphenazine-treated schizophrenic patients. Psychopharmacology. 2007;190:479–484
  14. Güzey C, Scordo MG, Spina E, Landsem VM, Spigset O. Antipsychotic-induced extrapyramidal symptoms in patients with schizophrenia: associations with dopamine and serotonin receptor and transporter polymorpshisms. Eur. J. Clin. Pharmacol. 2007;63:233–241
  15. Hellstrand M, Danielsen EA, Steen VM, Ekman A, Eriksson E, Nilsson CL. The ser9gly SNP in the dopamine D3 receptor causes a shift from cAMP related to PGE2 related signal transduction mechanisms in transfected CHO cells. J. Med. Genet. 2004;41(11):867–871
  16. Jönsson EG, Kaiser R, Brockmöller J, Nimgaonkar VL, Crocq MA. Meta-analysis of the dopamine D3 receptor gene (DRD3) Ser9Gly variant and schizophrenia. Psychiatr. Genet. 2004;14(1):9–12
  17. Kling-Petersen T, Ljung E, Svensson K. Effects on locomotor activity after local application of D3 preferring compounds in discrete areas of the rat brain. J. Neural Transm. Gen. Sect. 1995;102(3):209–220
  18. Lerer B, Segman RH, Fangerau H, et al. Pharmacogenetics of tardive dyskinesia: combined analysis of 780 patients supports association with dopamine D3 receptor gene Ser9Gly polymorphism. Neuropsychopharmacology. 2002;27:105–119
  19. Li B, Leal SM. Discovery of rare variants via sequencing: implications for the design of complex trait association studies. PLoS Genet. 2009;5(5):e1000481
  20. Lundstrom K, Turpin MP. Proposed schizophrenia-related gene polymorphism: expression of the Ser9Gly mutant human dopamine D3 receptor with the Semliki Forest virus system. Biochem. Biophys. Res. Commun. 1996;225(3):1068–1072
  21. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res. 2003;31(13):3812–3814
  22. Ramensky V, Bork P, Sunyaev S. Human non-synonymous SNPs: server and survey. Nucleic Acids Res. 2002;30(17):3894–3900
  23. Simpson GM, Angus JW. A rating scale for extra-pyramidal side effects. Acta Psychiatr. Scand. 1970;212:11–19
  24. Sokoloff P, Martres MP, Giros B, Bouthenet ML, Schwartz JC. The third dopamine receptor (D3) as a novel target for antipsychotics. Biochem. Pharmacol. 1992;43(4):659–666
  25. Suzuki M, Hurd YL, Sokoloff P, Schwartz JC, Sedvall G. D3 dopamine receptor mRNA is widely expressed in the human brain. Brain Res. 1998;779(1–2):58–74
  26. Yuan HY, Chiou JJ, Tseng WH, et al. FASTSNP: an always up-to-date and extendable service for SNP function analysis and prioritization. Nucleic Acids Res. 2006;34:W635–W641(Web Server issue)
  27. Zai CC, Tiwari AK, De Luca V, et al. Genetic study of BDNF, DRD3, and their interaction in tardive dyskinesia. Eur. Neuropsychopharmacol. 2009;19(5):317–328

PII: S0924-977X(10)00119-7

doi: 10.1016/j.euroneuro.2010.06.006

European Neuropsychopharmacology
Volume 21, Issue 4 , Pages 294-299 , April 2011

Article Tools

* Image Usage & Resolution